Related Experiment Video
Updated: Nov 16, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
CREB-binding protein (CREBBP) and preeclampsia: a new promising target gene
Hossein Sadeghi1, Sahra Esmkhani2,3, Reihaneh Pirjani4
1Genomic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Insights
Preeclampsia (PE) involves higher CREBBP gene expression in placental tissue. This finding suggests CREBBP may play a role in PE development and could be a future therapeutic target.
Area of Science:
- Obstetrics and Gynecology
- Molecular Biology
- Genetics
Background:
- Preeclampsia (PE) is a significant pregnancy complication causing maternal and neonatal mortality.
- Increased PE incidence is observed in pregnancies with fetal Rubinstein-Taybi Syndrome, linked to CREBBP gene mutations.
Purpose of the Study:
- To compare CREBBP gene expression levels between preeclamptic and healthy placentas.
- To investigate the differential expression of CREBBP in maternal versus fetal placental tissues.
Main Methods:
- Quantitative real-time polymerase chain reaction (qRT-PCR) was used.
- One hundred placental biopsies were analyzed from PE patients and healthy controls.
- CREBBP expression was assessed in both maternal and fetal placental sides.
Main Results:
- CREBBP gene expression was significantly higher in preeclamptic placentas compared to controls (Fold change = 2.158, P = 0.018).
- A trend towards higher CREBBP expression was noted in the fetal placental side, but this difference was not statistically significant (Fold change = 1.713, P = 0.254).
Conclusions:
- The study indicates a role for CREBBP in the pathogenesis of preeclampsia.
- Given CREBBP's function in angiogenesis and hypoxia, it represents a potential target for future research and therapeutic strategies.
Abstract:
Preeclampsia (PE) is a major complication of pregnancy and remains a leading cause of neonatal and maternal mortality worldwide. Several studies have revealed that the incidence of preeclampsia is high in mothers who carried a fetus with Rubinstein-Taybi Syndrome due to the mutation in CREBBP. We aimed to compare the expression level of the CERBBP gene between preeclamptic and healthy placenta in our study. The expression level of CREBBP gene was evaluated in a total of one hundred placental biopsies from PE patients and healthy pregnant women after delivery using quantitative real-time polymerase chain reaction (qRT-PCR). Moreover, the differential expression of CREBBP was assessed between the maternal and fetal sides of the placenta. Expression of the CREBBP gene was higher in preeclampsia patients compared with the controls (Fold change = 2.158; P = 0.018). Moreover, the gene expression was slightly higher in the fetal side of the placenta, although it was not significantly different (Fold change = 1.713, P = 0.254). Our findings show a role for CREBBP in the pathogenesis of PE. Due to the important role of CREBBP in angiogenesis and hypoxia, the gene may serve as a promising target in future studies.
More Related Videos
Related Concept Videos
Cell Specific Gene Expression
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
GPCRs Regulate Adenylyl Cylase Activity
Regulation of the Unfolded Protein Response

